Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Meril Nordic AB
AB
Active
Org 5594781840
Fabriksgatan 1, 412 50
Göteborg
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2024
5-9 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Meril Nordic AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2025
EBITDA
SEK millions
0M
-1M
-2M
-3M
-3M
-3M
2025
Income statement
SEK thousands
Item
2025
Revenue
732
Staff expenses
—
EBITDA
−2 599
Depreciation & amort.
−0
EBIT
−2 599
Net financials
3
Profit before tax
−2 596
Tax
−0
Net profit
−2 596
Balance sheet
SEK thousands
Item
2025
Total assets
27 895
Equity
−1 226
Long-term debt
0
Short-term debt
29 121
Total debt
29 121
Financial ratios
5-year trend
EBITDA margin
-355.1%
This company
15.8%
Market median
-2347% vs market
2025
2025
Equity ratio
-4.4%
This company
38.2%
Market median
-112% vs market
2025
2025
Return on equity
-259600000.0%
This company
18.4%
Market median
-1410869665% vs market
2025
2025
Net profit margin
-354.6%
This company
8.1%
Market median
-4478% vs market
2025
2025
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
2025
2025
Debt / equity
23.75×
This company
0.62×
Market median
-3731% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
View
PDF
More on Meril Nordic AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
